NEURODEX
NeuroDex is a developer of diagnostics, theranostics, prognostics, and pharmacodynamic analysis in the neurology space. The company's proprietary neuron-derived exosome isolation technology can be applied across a number of neurological indications. With the technology, a simple blood draw could allow physicians and researchers to open a window into the brain. NeuroDex's technology has the potential to enable early detection, patient stratification, and disease monitoring, which will enable the first disease-modifying treatment for Alzheimer's.
NEURODEX
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2018-01-01
Address:
Natick, Massachusetts, United States
Country:
United States
Website Url:
http://www.neurodex.co
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content Wix
Similar Organizations
PreemaTEX
PreemaTEX is a developer of diagnostic tests to assess a woman’s risk for preterm delivery early in pregnancy.
Quantason
Quantason develops bi-modal US/IDUS™ platform technology for diagnostic imaging and active screening.
Spectral Platforms
Spectral Platforms develops tools for rapid diagnosis of infectious diseases in clinical samples.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Investors List
ICV Group
ICV Group investment in Seed Round - NeuroDex
Official Site Inspections
http://www.neurodex.co
- Host name: 162-215-97-15.unifiedlayer.com
- IP address: 162.215.97.15
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
